Last reviewed · How we verify

NCT06899919: PROMETHEE

Efficacy and Safety of Light Compression System in the Local Treatment of Mixed Leg Ulcers (PROMETHEE Clinical Investigation)

Recruiting now NA Last updated 8 April 2025
What this trial tests

NA trial testing Treatment with light compression systeme during 16-week treatment period (6 medical visits are planned: D0, W2, W4, W8, W12, W16) in Leg Ulcers in 210 participants. Currently enrolling.

Timeline
29 March 2025
Primary endpoint
31 March 2027
30 September 2027

Quick facts

Lead sponsorLaboratoires URGO
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment210
Start date29 March 2025
Primary completion31 March 2027
Estimated completion30 September 2027
Sites3 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Laboratoires URGO — full company profile →

Who can join

18 and older, any sex, with Leg Ulcers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the efficacy (wound epithelialization and time to closure) and safety (emergence and nature of adverse event) of a lite compression system versus a tubular bandage in the local treatment of mixed leg ulcers: prospective multicenter, randomized controlled, open-label french clinical study

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Laboratoires URGO trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06899919.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing